UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.819

Sortiert nach

The tumor microenvironment shapes hallmarks of mature B-cell malignancies

Oncogene, 2015-09, Vol.34 (36), p.4673-4682

2015

Link zum Volltext

Verfügbarkeit prüfen

Myc represses miR-15a miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

Oncogene, 2012-06, Vol.31 (24), p.3002-3008

2012

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

Leukemia, 2003-06, Vol.17 (6), p.1175-1182

2003

Link zum Volltext

Verfügbarkeit prüfen

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas

Leukemia, 2011-01, Vol.25 (1), p.145-152

2011

Link zum Volltext

Verfügbarkeit prüfen

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

British journal of cancer, 2014-11, Vol.111 (10), p.1932-1944

2014

Link zum Volltext

Verfügbarkeit prüfen

Surgery for valvular heart disease: a population-based study in a Brazilian urban center

PloS one, 2012-05, Vol.7 (5), p.e37855-e37855

2012

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

Leukemia, 2009-01, Vol.23 (1), p.170-177

2009

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-hodgkin's lymphoma cells

Leukemia, 2007-07, Vol.21 (7), p.1521-1531

2007

Link zum Volltext

Verfügbarkeit prüfen

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation

Leukemia, 2001-08, Vol.15 (8), p.1232-1239

2001

Link zum Volltext

Verfügbarkeit prüfen

Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (15), p.4161-4166

2000

Link zum Volltext

Verfügbarkeit prüfen

Cell adhesion mediated drug resistance (CAM-DR) : Role of integrins and resistance to apoptosis in human myeloma cell lines

Blood, 1999-03, Vol.93 (5), p.1658-1667

1999

Link zum Volltext

Verfügbarkeit prüfen

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

JNCI : Journal of the National Cancer Institute, 1999-03, Vol.91 (5), p.429-433

1999

Link zum Volltext

Verfügbarkeit prüfen

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity

Leukemia, 2013-12, Vol.27 (12), p.2341-2350

2013

Link zum Volltext

Verfügbarkeit prüfen

P-Glycoprotein Expression and Function in Circulating Blood Cells From Normal Volunteers

Blood, 1994-05, Vol.83 (9), p.2451-2458

1994

Link zum Volltext

Verfügbarkeit prüfen

The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells

Leukemia, 2003-02, Vol.17 (2), p.451-457

2003

Link zum Volltext

Verfügbarkeit prüfen

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Journal of clinical oncology, 1998-03, Vol.16 (3), p.994-999

1998

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of the Major Vault Transporter Protein Lung-Resistance Protein Predicts Treatment Outcome in Acute Myeloid Leukemia

Blood, 1996-03, Vol.87 (6), p.2464-2469

1996

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines

Cancer research (Chicago, Ill.), 2000-05, Vol.60 (10), p.2589-2593

2000

Link zum Volltext

Verfügbarkeit prüfen

Drug resistance in multiple myeloma: approaches to circumvention

Seminars in oncology, 1999-10, Vol.26 (5 Suppl 13), p.23-27

1999

Link zum Volltext

Verfügbarkeit prüfen

β1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells

British journal of haematology, 2007-01, Vol.136 (2), p.269-275

2007

Link zum Volltext

Verfügbarkeit prüfen

pH and drug resistance. I. functional expression of plasmalemmal V-type H +-ATPase in drug-resistant human breast carcinoma cell lines

Biochemical pharmacology, 1999-05, Vol.57 (9), p.1037-1046

1999

Link zum Volltext

Verfügbarkeit prüfen

Selection for drug resistance results in resistance to Fas-mediated apoptosis

Blood, 1997-03, Vol.89 (6), p.1854-1861

1997

Link zum Volltext

Verfügbarkeit prüfen

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Journal of clinical oncology, 1989-04, Vol.7 (4), p.415-424

1989

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of drug resistance in hematologic malignancies

Seminars in hematology, 1997-10, Vol.34 (4 Suppl 5), p.3-8

Dalton, W S

1997

Link zum Volltext

Verfügbarkeit prüfen

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line

Cancer research (Chicago, Ill.), 1999-03, Vol.59 (5), p.1021-1028

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 3.819

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.185)
Mit Volltextzugriff
(3.233)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.791)
Ingenta
(1.523)
EZB Free E-Journals
(1.405)
Journals@Ovid Ovid Full Text
(1.207)
Single Journals
(970)
Elsevier ScienceDirect Journals Complete
(678)
IngentaConnect Journals
(589)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(511)
Wiley Online Library
(419)
Wiley Online Library Full Collection 2018
(256)
JSTOR Complete Journals
(226)
Oxford University Press Journals Current
(200)
SpringerLink (Online service)
(197)
EBSCOhost Business Source Ultimate
(169)
IEEE Electronic Library (IEL)
(142)
SAGE Publications
(141)
Nature
(135)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(128)
Taylor & Francis
(121)
Taylor & Francis:Master (3349 titles)
(119)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Stroke
(70)
Journal Of Neurotrauma
(61)
Monthly Notices Of The Royal Astronomical Society
(57)
Physical Review Letters
(56)
Journal Of Cerebral Blood Flow And Metabolism
(50)
Blood
(44)
Plos One
(41)
The New England Journal Of Medicine
(40)
Cancer Research
(36)
The Lancet
(33)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The tumor microenvironment shapes hallmarks of mature B-cell malignancies

Myc represses miR-15a miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas

Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas

A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours

Surgery for valvular heart disease: a population-based study in a Brazilian urban center

Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis

Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-κB (RelB/p52) in non-hodgkin's lymphoma cells

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and γ-irradiation

Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray

Cell adhesion mediated drug resistance (CAM-DR) : Role of integrins and resistance to apoptosis in human myeloma cell lines

Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity

P-Glycoprotein Expression and Function in Circulating Blood Cells From Normal Volunteers

The farnesyl transferase inhibitor, FTI-277, inhibits growth and induces apoptosis in drug-resistant myeloma tumor cells

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study

Overexpression of the Major Vault Transporter Protein Lung-Resistance Protein Predicts Treatment Outcome in Acute Myeloid Leukemia

Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines

Drug resistance in multiple myeloma: approaches to circumvention

β1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells

pH and drug resistance. I. functional expression of plasmalemmal V-type H +-ATPase in drug-resistant human breast carcinoma cell lines

Selection for drug resistance results in resistance to Fas-mediated apoptosis

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy

Mechanisms of drug resistance in hematologic malignancies

Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line

Suchergebnisse filtern